HNL News

September 30, 2022

Monkeypox Know the FAQs

Signs and Symptoms
Read More
September 23, 2022

HNL Lab Medicine Career Fair

HNL Lab Medicine is excited to host our next Career Fair, Thursday, October 6th in the Roble Road parking lot.
Read More
September 19, 2022

Common Labeling Mishaps

Ways to avoid common specimen labeling issues.
Read More
September 10, 2022

Redesign Underway

Are you tired of stuffy waiting rooms? So are we! HNL Lab Medicine is excited to announce our brand-new renovation project. Our HNL Patient Service Centers (PSCs) are undergoing a redesign!

Read More
September 01, 2022

Entrepreneurs HNL is sponsoring the FACTORY’s StartUp Lehigh Valley

More than $30,000 in prize money up for grabs in 4th annual StartUp Lehigh Valley pitch competition for entrepreneurs
 
StartUp Lehigh Valley, a pitch competition for entrepreneurs developed and hosted by Factory LLC, is back for a fourth year!
 
“As a company that recognizes the value of innovation, HNL Lab Medicine is thrilled to see what the brilliant minds of the Lehigh Valley have in store for us,” says Martin Till, President and CEO of HNL Lab Medicine. “In our industry, innovation saves lives, so we strongly encourage the entrepreneurial spirit when it comes to new ideas and fresh perspectives.”
Read More
Clinical Departments

Cytogenetics

Cytogenetic testing is utilized to detect numerical and structural chromosome abnormalities in metaphase cells.

HNL Lab Medicine’s state-of-the-art Cytogenetics laboratory provides the most advanced chromosome analysis for identifying and diagnosing genetic abnormalities, to be used in:

  • Cancer Diagnosis
  • Disease Classification
  • Monitoring and Treatment Decisions
  • Understanding a Genetic Cause of Spontaneous Miscarriages or Infertility
 
 

As the medical world moves toward personalized medicine, cytogenetics enables us to be a partner in the effort to help treat the right patient with the right drug at the right time.

Utilizing both conventional karyotyping and FISH (fluorescent in situ hybridization), we can diagnose, treat or predict risk for individuals with:

  • Congenital Malformations
  • Mental Retardation
  • Multiple Spontaneous Miscarriages
  • Fertility Issues
  • Products of Conception
  • Hematological Malignancies
  • Neoplastic Processes